B-Cell Proliferation Induced by Various Stimuli In Vitro
. | [3H]-TdR Incorporation* (cpm) . | Response in Telomerase Activity† (%) . |
---|---|---|
Medium | 573 ± 68 | Not detectable |
Anti-IgM (10 μg/mL) | 1,652 ± 473 | 0.2 |
Anti-IgM-Beads (10 μg/mL) | 7,267 ± 77 | 115.5 |
Anti-IgM + anti-CD40 (10 μg/mL) | 6,716 ± 290 | 100 |
Anti-IgM + IL-2 (100 U/mL) | 6,228 ± 314 | 32.7 |
Anti-IgM + IL-4 (0.5 U/mL) | 6,608 ± 793 | 84.3 |
Anti-IgM + IL-6 (100 U/mL) | 990 ± 106 | 0.4 |
Anti-IgM + IL-13 (10 ng/mL) | 6,398 ± 524 | 62.1 |
. | [3H]-TdR Incorporation* (cpm) . | Response in Telomerase Activity† (%) . |
---|---|---|
Medium | 573 ± 68 | Not detectable |
Anti-IgM (10 μg/mL) | 1,652 ± 473 | 0.2 |
Anti-IgM-Beads (10 μg/mL) | 7,267 ± 77 | 115.5 |
Anti-IgM + anti-CD40 (10 μg/mL) | 6,716 ± 290 | 100 |
Anti-IgM + IL-2 (100 U/mL) | 6,228 ± 314 | 32.7 |
Anti-IgM + IL-4 (0.5 U/mL) | 6,608 ± 793 | 84.3 |
Anti-IgM + IL-6 (100 U/mL) | 990 ± 106 | 0.4 |
Anti-IgM + IL-13 (10 ng/mL) | 6,398 ± 524 | 62.1 |